| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2141.2002.03616.X |
| P8608 | Fatcat ID | release_bvfao46bfbcsdbxqwbk5bnnxmq |
| P698 | PubMed publication ID | 12139764 |
| P5875 | ResearchGate publication ID | 11241766 |
| P2093 | author name string | Ric Swindell | |
| William Randall | |||
| Rajesh Chopra | |||
| Colin R Callow | |||
| P2860 | cites work | The quantitative relation between platelet count and hemorrhage in patients with acute leukemia | Q33353564 |
| Controversies in transfusion medicine. Prophylactic platelet transfusion revisited after 25 years: con | Q33366000 | ||
| Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia | Q33371869 | ||
| The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | Q33501152 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | platelet transfusion | Q23925170 |
| P304 | page(s) | 677-682 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy | |
| P478 | volume | 118 |
| Q24186913 | A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation |
| Q33375060 | Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L. |
| Q33392598 | An audit of platelet transfusion within the Wellington Cancer Centre |
| Q24187751 | Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation |
| Q24186359 | Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation |
| Q28288397 | Evaluation of platelet transfusion triggers in a tertiary-care hospital |
| Q33426701 | Feasibility of an Isometric Maximal Voluntary Contraction Test in Hematological Cancer Patients during Thrombocytopenia |
| Q64232456 | How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa |
| Q33385493 | Is physical exercise possible in patients with critical cytopenia undergoing intensive chemotherapy for acute leukaemia or aggressive lymphoma? |
| Q36194564 | Management of bleeding in the terminally ill patient |
| Q33395035 | Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia |
| Q33361167 | Optimizing platelet transfusion therapy |
| Q33376399 | Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L. |
| Q24197779 | Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation |
| Q33375990 | Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review |
| Q33365386 | Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura |
| Q34492729 | Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period |
| Q37209117 | Recommendations for the transfusion of plasma and platelets |
| Q40083311 | Safety and Feasibility of Rehabilitation Interventions in Children Undergoing Hematopoietic Stem Cell Transplant with Thrombocytopenia. |
| Q52622931 | The role of thromboelastography in predicting hemorrhage risk in patients with leukemia. |
| Q33424052 | Thromboelastography (TEG®) compared with total platelet count in thrombocytopenia haematological malignancy patients with bleeding: a pilot observational study |
| Q33403558 | Use of fresh platelet concentrate or lyophilized platelets in thrombocytopenic dogs with clinical signs of hemorrhage: a preliminary trial in 37 dogs |
Search more.